Literature DB >> 18619871

Systemic host immuno-inflammatory response to dental extractions and periodontitis.

Farah K Bahrani-Mougeot1, Martin Thornhill, Howell Sasser, Ian Marriott, Michael T Brennan, Silvana Papagerakis, Shirley Coleman, Philip C Fox, Peter B Lockhart.   

Abstract

OBJECTIVES: Little is known about the host immuno-inflammatory response to dental extractions. The purpose of this pilot clinical study was to explore the effect of both periodontitis and dental extractions on the host systemic immuno-inflammatory response. STUDY
DESIGN: We recruited and collected baseline blood samples on 41 essentially healthy patients. A subset of 22 subjects underwent single (n = 11) or multiple (n = 11) tooth extractions with additional blood samples taken at 1 hour following single tooth extraction and at 8 and 24 hours following multiple tooth extractions. Samples were used for determination of an array of 12 cytokines known to play key roles in innate and adaptive immunity.
RESULTS: There was no significant difference in cytokine levels between the pre- and post-tooth extraction samples for either extraction group for the time points measured. Nor was there a positive relationship between the level of any of the cytokines and periodontal disease status as measured by mean probing depths and other periodontal disease parameters.
CONCLUSION: Our pilot data suggest that the body is well adjusted to deal with the inflammation and bacteremia associated with dental extractions and periodontal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619871     DOI: 10.1016/j.tripleo.2008.02.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  1 in total

1.  Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.

Authors:  Anna Kaisa Kylmä; Lauri Jouhi; Dyah Listyarifah; Hesham Mohamed; Antti Mäkitie; Satu Maria Remes; Caj Haglund; Timo Atula; Mikko T Nieminen; Timo Sorsa; Jaana Hagström
Journal:  Br J Cancer       Date:  2018-06-22       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.